Alexandru Saveanu Selected Research

Alexandru Saveanu Research Topics

Disease

13	Neoplasms (Cancer) 09/2017 - 01/2006
13	Pituitary Neoplasms (Pituitary Adenoma) 09/2017 - 01/2006
8	Hypopituitarism (Sheehan's Syndrome) 03/2024 - 11/2008
6	Combined Pituitary Hormone Deficiency 11/2019 - 08/2005
6	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2019 - 04/2014
4	Hypothyroidism 01/2023 - 08/2005
4	Prolactinoma (Prolactinomas) 05/2012 - 01/2006
4	Adenoma (Adenomas) 03/2012 - 06/2008
3	Acromegaly 06/2021 - 05/2007
3	Growth Hormone-Secreting Pituitary Adenoma 06/2021 - 01/2006
2	Rare Diseases (Rare Disease) 03/2024 - 04/2012
2	Diabetes Insipidus 03/2024 - 03/2024
2	Meningioma (Meningiomas) 09/2017 - 08/2017
2	Primitive Neuroectodermal Tumors (PNET) 06/2017 - 10/2014
2	Pheochromocytoma 12/2013 - 04/2011
1	Morbid Obesity 07/2023
1	Obesity 07/2023
1	COVID-19 01/2023
1	Hypoglycemia (Reactive Hypoglycemia) 01/2023
1	Agammaglobulinemia (Hypogammaglobulinemia) 01/2023
1	Common Variable Immunodeficiency 01/2023
1	Jaundice (Icterus) 01/2022
1	Cognitive Dysfunction 01/2022
1	Pituitary ACTH Hypersecretion 08/2017
1	Delayed Puberty 12/2012
1	Demyelinating Diseases (Demyelinating Disease) 12/2011
1	Hyponatremia 12/2011
1	Hyperthyroidism 06/2011
1	Paraganglioma (Paragangliomas) 04/2011
1	Infections 12/2008
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2005
1	Carcinoma (Carcinomatosis) 12/2005

Drug/Important Bio-Agent (IBA)

17	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 06/2021 - 12/2005
12	Octreotide (Sandostatin)FDA LinkGeneric 09/2017 - 01/2006
11	Dopamine (Intropin)FDA LinkGeneric 06/2021 - 12/2005
8	Transcription Factors (Transcription Factor)IBA 01/2023 - 08/2005
8	Somatostatin Receptors (Somatostatin Receptor)IBA 09/2017 - 04/2007
7	ProlactinIBA 03/2024 - 08/2005
6	Growth Hormone (Somatotropin)IBA 03/2024 - 12/2008
6	Adrenocorticotropic Hormone (ACTH)FDA Link 03/2024 - 09/2011
6	Hormones (Hormone)IBA 01/2023 - 04/2007
6	Cabergoline FDA LinkGeneric 05/2012 - 01/2006
5	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 03/2024 - 06/2011
5	pasireotideIBA 08/2017 - 01/2006
5	Dopamine Receptors (Dopamine Receptor)IBA 12/2013 - 12/2005
4	Messenger RNA (mRNA)IBA 09/2017 - 12/2008
4	TBR-760IBA 05/2012 - 01/2006
3	Immunoglobulins (Immunoglobulin)IBA 01/2023 - 06/2016
3	LigandsIBA 06/2009 - 01/2006
2	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2023 - 12/2011
2	Everolimus FDA Link 08/2017 - 06/2017
2	Dopamine Agonists (Dopamine Agonist)IBA 05/2012 - 05/2008
2	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 06/2011 - 01/2006
1	Vasopressins (Vasopressin)IBA 03/2024
1	Follicle Stimulating Hormone (Follitropin)FDA Link 03/2024
1	Anterior Pituitary HormonesIBA 03/2024
1	Luteinizing Hormone (Lutropin)FDA LinkGeneric 03/2024
1	Arginine Vasopressin (Argipressin)IBA 03/2024
1	Pituitary HormonesIBA 03/2024
1	setmelanotideIBA 07/2023
1	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 07/2023
1	Immunoglobulin A (IgA)IBA 01/2023
1	Immunoglobulin M (IgM)IBA 01/2023
1	Isolated ACTH DeficiencyIBA 01/2022
1	Protein Isoforms (Isoforms)IBA 01/2021
1	Adenosine Monophosphate (AMP)IBA 01/2019
1	TOR Serine-Threonine KinasesIBA 06/2017
1	Glycoproteins (Glycoprotein)IBA 06/2016
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 06/2016
1	Chromogranin AIBA 10/2014
1	Proteins (Proteins, Gene)FDA Link 12/2013
1	Iodine-123IBA 12/2013
1	3- iodo- 2- hydroxy- 6- methoxy- N- ((1- ethyl- 2- pyrrolidinyl)methyl)benzamideIBA 12/2013
1	GonadotropinsIBA 12/2012
1	GlucocorticoidsIBA 12/2011
1	Colloids (Colloid)IBA 12/2011
1	Codon (Codons)IBA 09/2011
1	Thyroid HormonesIBA 06/2011
1	Radioisotopes (Radionuclides)IBA 04/2011
1	N-acetyltalosaminuronic acid (NAT)IBA 04/2011
1	Vesicular Monoamine Transport Proteins (Vesicular Monoamine Transporter)IBA 04/2011
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 04/2011
1	somatostatin receptor 5IBA 05/2010
1	lanreotide (Somatuline)FDA Link 06/2009
1	Bromocriptine (Parlodel)FDA LinkGeneric 06/2009
1	Dihydrotachysterol (AT 10)IBA 12/2008
1	BIM 23926IBA 05/2008
1	BIM 23206IBA 05/2008
1	ThymidineIBA 05/2008
1	somatostatin receptor type 1IBA 05/2008
1	Dopamine Agents (Dopaminergic Agents)IBA 04/2007
1	BIM 23268IBA 01/2006
1	Human Growth Hormone (Saizen)FDA LinkGeneric 01/2006

Therapy/Procedure

13	Therapeutics 06/2021 - 04/2007
1	Critical Care (Surgical Intensive Care) 12/2011